These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 34768921)

  • 21. Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer.
    Alam M; Mishra R
    Life Sci; 2021 Sep; 280():119705. PubMed ID: 34111459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma.
    Maji S; Shriwas O; Samal SK; Priyadarshini M; Rath R; Panda S; Das Majumdar SK; Muduly DK; Dash R
    Carcinogenesis; 2019 Mar; 40(1):173-183. PubMed ID: 30395230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rational combination with PDK1 inhibition overcomes cetuximab resistance in head and neck squamous cell carcinoma.
    Lu H; Lu Y; Xie Y; Qiu S; Li X; Fan Z
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supramolecular nanodrug targeting CDK4/6 overcomes BAG1 mediated cisplatin resistance in oral squamous cell carcinoma.
    Zhao B; Qin X; Fu R; Yang M; Hu X; Zhao S; Cui Y; Guo Q; Zhou W
    J Control Release; 2024 Apr; 368():623-636. PubMed ID: 38479445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
    Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
    Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 Promotes chemoresponsiveness by regulating hexokinase II gene transcription and metabolic reprogramming in epithelial ovarian cancer.
    Han CY; Patten DA; Lee SG; Parks RJ; Chan DW; Harper ME; Tsang BK
    Mol Carcinog; 2019 Nov; 58(11):2161-2174. PubMed ID: 31486135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined inhibition of RNA polymerase I and mTORC1/2 synergize to combat oral squamous cell carcinoma.
    Shi S; Luo H; Wang L; Li H; Liang Y; Xia J; Wang Z; Cheng B; Huang L; Liao G; Xu B
    Biomed Pharmacother; 2021 Jan; 133():110906. PubMed ID: 33190037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC.
    Wang LH; Xu M; Fu LQ; Chen XY; Yang F
    Sci Rep; 2018 Aug; 8(1):12776. PubMed ID: 30143678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors.
    Iwase M; Yoshiba S; Uchid M; Takaoka S; Kurihara Y; Ito D; Hatori M; Shintani S
    Int J Oncol; 2007 Nov; 31(5):1141-7. PubMed ID: 17912441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Puerarin Suppresses Glycolysis and Increases Cisplatin Chemosensitivity in Oral Squamous Cell Carcinoma
    Cai Y; Gao Q; Meng JH; Chen L
    Nutr Cancer; 2023; 75(3):1028-1037. PubMed ID: 36718661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-4290 suppresses PDK1-mediated glycolysis to enhance the sensitivity of gastric cancer cell to cisplatin.
    Qian Y; Wu X; Wang H; Hou G; Han X; Song W
    Braz J Med Biol Res; 2020; 53(5):e9330. PubMed ID: 32321153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isoorientin inhibits epithelial-to-mesenchymal properties and cancer stem-cell-like features in oral squamous cell carcinoma by blocking Wnt/β-catenin/STAT3 axis.
    Liu SC; Huang CS; Huang CM; Hsieh MS; Huang MS; Fong IH; Yeh CT; Lin CC
    Toxicol Appl Pharmacol; 2021 Aug; 424():115581. PubMed ID: 34019859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer stemness of CD10-positive cells regulated by Hedgehog pathway promotes the resistance to cisplatin in oral squamous cell carcinoma.
    Wang Y; Li Q; Xu L; Chen J; Pu Y; Wang L; Sun H; Guo Y; Guo C
    Oral Dis; 2021 Sep; 27(6):1403-1411. PubMed ID: 33037760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma.
    Li M; Gao F; Yu X; Zhao Q; Zhou L; Liu W; Li W
    J Exp Clin Cancer Res; 2020 May; 39(1):88. PubMed ID: 32410646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis.
    Li M; Gao F; Zhao Q; Zuo H; Liu W; Li W
    Cell Death Dis; 2020 May; 11(5):381. PubMed ID: 32424132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CMTM6 attenuates cisplatin-induced cell death in OSCC by regulating AKT/c-Myc-driven ribosome biogenesis.
    Mohapatra P; Mohanty S; Ansari SA; Shriwas O; Ghosh A; Rath R; Majumdar SKD; Swain RK; Raghav SK; Dash R
    FASEB J; 2022 Oct; 36(10):e22566. PubMed ID: 36165231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
    Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
    J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells.
    Aggarwal S; John S; Sapra L; Sharma SC; Das SN
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):451-461. PubMed ID: 30519710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PDK1 Mediates
    Sambandam V; Frederick MJ; Shen L; Tong P; Rao X; Peng S; Singh R; Mazumdar T; Huang C; Li Q; Pickering CR; Myers JN; Wang J; Johnson FM
    Clin Cancer Res; 2019 Jun; 25(11):3329-3340. PubMed ID: 30770351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.